About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 176 record(s)
Req # A-2021-002095
Adverse Drug Reactions (ADRs) for Furosemide, Zopiclone, Leflunomide. Report numbers: E2B_04913154, E2B_04909974, E2B_04643237, E2B_04934504.Organization: Health Canada
August 2022
Req # A-2021-002118
Adverse Drug Reaction (ADR) for FUROSEMIDE. Report number: E2B_04801670.Organization: Health Canada
August 2022
Req # A-2022-000294
Adverse Drug Reactions (ADRs) for Intron A. Report numbers: E2B_03022099, E2B_03022079, E2B_03022075, E2B_02726169.Organization: Health Canada
August 2022
Req # A-2022-000401
Adverse Drug Reactions (ADRs). Report numbers: E2B_03468319, E2B_03462681, E2B_03464451, E2B_03464474, E2B_03464489, E2B_03464487, E2B_03566985.Organization: Health Canada
August 2022
Req # A-2017-001792
The most recent Drug Establishment Licence for Auro Pharma including any annexes listing foreign buildings and the drugs they are licensed to produce.Organization: Health Canada
July 2022
Req # A-2018-000944
All documents describing any and all features of the "class exemption" issued by the Minister of Health under s. 56 of the Controlled Drugs and Substances.Organization: Health Canada
July 2022
Req # A-2021-001353
All historical product labels for pesticides containing the chemical Paraquat from January 1, 1960 to November 29, 2021 in paper format at the time of this request.Organization: Health Canada
July 2022
Req # A-2022-000067
A list of the grants and other payments made by Health Canada to Physicians for A Smoke Free Canada from January 1, 2012 to December 31, 2021. Include the amount paid and when they were paid. A list of the documents or services or other work products Health Canada has received in exchange for these grants and other payments for the same time period (January 1, 2012 to December 31, 2021).Organization: Health Canada
July 2022
Req # A-2022-000155
Footnote #37 of the Evaluation of the Health Portfolio Tobacco and Vaping Activities 2016-17 to 2020-21, made public on Health Canada's website on April 26, 2022 makes reference to the following document: "Health Canada (2017). Technical Reference Sheet Harm Reduction & Cessation". A copy of this document/report.Organization: Health Canada
July 2022
Req # A-2021-001045
Adverse Drug Reactions (ADRs) for ZOPICLONE. Report numbers: E2B_03811824, E2B_03841105, E2B_03840754.Organization: Health Canada
July 2022